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Abstract
Background: Fibin was initially discovered as a secreted signal molecule essential for pectoral fin bud initiation in
zebrafish. Currently, there is little information about the molecular architecture and biological relevance of fibin in
humans and other mammals.
Results: Fibin is expressed in cerebellum, skeletal muscle and many other embryonic and adult mouse tissues
suggesting not only a role during embryonic development but also in adult functions. A 2.5-kbp genomic
sequence fragment upstream of the coding sequence is sufficient to drive and regulate fibin expression through
stimulation by glucocorticoids, activators of the protein kinase C signalling pathways and manganese ions. Fibin is
an evolutionarily conserved protein, carries a cleavable signal peptide (amino acids 1-18) and is glycosylated at
Asn
30. The two conserved cysteines participate in intermolecular disulfide bond and multimer formation. Although
fibin displays all features of a secretory protein, it is mostly retained in the endoplasmic reticulum when
heterologously expressed.
Conclusion: Fibin is functionally relevant during embryogenesis and adult life. Its expression is regulated by a
number of cellular signalling pathways and the protein is routed via the secretory pathway. However, proper
secretion presumably requires an unknown covalently-linked or associated co-factor.
Background
Fibin, a secreted protein, was recently described as a
novel growth factor found in various embryonic tissues
of zebrafish and in the forelimb buds of mouse embryos
[1]. The fibin sequence exhibits no homology to any
known proteins. In zebrafish, the functional knockdown
of fibin resulted in an absence of pectoral fins [1]. There
are a number of factors involved in limb development;
among them retinaldehyde dehydrogenase type 2 [2],
the fibroblast growth factors fgf16 [3], fgf24 [4] and the
transcription factor tbx5 [5]. Mutations in the tbx5 gene
cause the Holt-Oram syndrome, which is characterized
by defects of the upper limbs and heart [6]. Interest-
ingly, fibin induces the expression of tbx5 via an
unknown signalling cascade [1]. The findings suggest
that fibin is essential for the pectoral fin bud formation
during embryogenesis. However, human hereditary
diseases caused by mutation of the fibin gene are not
known yet.
Fibin attracted our attention because fibin mRNA
levels were increased in the kidneys of newborn mice
with X-linked nephrogenic diabetes insipidus [7].
Further, in-depth screening of public sources revealed
t h a tf i b i na p p e a r st ob eh i g h l ye x p r e s s e dn o to n l yi n
embryonic stages, but also in a number of tissues in
postnatal and adult stages, which implicates functions
after embryonic ontogenesis. In the present study, we
provide comprehensive data on its evolutionary origin,
structural conservation, expression profiles, expression
regulation, cellular targeting and protein biochemistry
which includes heterologous protein expression and
refolding. Although fibin is routed through the endo-
plasmic reticulum (ER) we found no significant evidence
of secretion. We show that fibin is posttranslationally
modified and forms dimers when heterologously
expressed. Our data suggest that fibin may require yet
unknown accessory proteins for proper function. * Correspondence: schoberg@medizin.uni-leipzig.de
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Genomic organization, expression and expression
regulation of fibin
Initial investigations mining public sequence data sources
(EST data bases) revealed that human and mouse fibin
transcripts are present in a number of different tissues,
such as bones, kidney and lung, and also during several
ontogenetic stages (see http://www.ncbi.nlm.nih.gov/Uni-
Gene/ESTProfileViewer.cgi?uglist=Hs.712718; http://
www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?
uglist=Mm.291809). Comparison of fibin mRNA and
genomic sequences in humans and mice provided no
indication of transcript splicing or editing. More detailed
information of the genomic structure and transcript
length are shown in Additional file 1, Figure S1. To map
putative cis-acting elements in the 5’ flanking region the
MatInspector online software was used. We identified
several binding sites for the glucocorticoid receptor,
cAMP responsive element protein, NF-Ba n dW n t -
activated LEF/TCF transcriptional factors (Figure 1).
To experimentally substantiate EST data, we performed
qPCR studies with cDNA of various tissues and at different
mouse embryonic stages in relation to b2-microglobulin.
As shown in Figure 2A, increased fibin expression was
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LEF/TCF 
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-587 ttgtagagtcttcccttccaaccttTAAAaagcgaccctgtacctttaatagtggagacctggtga
TATA-box 
-521 gaggttcttttccaaacttgttccctggcttccaagTGACgaaaccagctgtaatttgagagcaga
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Figure 1 Putative cis-acting elements of the 5’-flanking region
of the human fibin gene. Grey boxes indicate the transcription
consensus-binding sequences of glucocorticoid-responsive and
-related elements (GRE), cAMP responsive elements (CRE), LEF/TCF,
NF-B, AP-1, Nrf2 and TATA binding protein (TATA) factors. EST
alignments (see Additional file 1, Figure S1) indicated more than
one transcriptional start site (TSP). TSP indicates the most frequently
5’-end of ESTs. The translation start codon is underlined.
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Figure 2 Fibin mRNA expression estimated by qPCR. Total RNA
was extracted either from several mouse tissues or cell lines and
used for reverse transcriptase reaction. qPCR was carried out with
transcript-specific primers pairs. (A) Fibin mRNA expression of tissues
from three adult mice is given as x-fold over fibin expression in
liver. Data are shown as means ± SEM from three different tissue
and cell preparations. (B) At indicated days after fertilization
embryos were dissected from uterus. Trunks, forelimbs and heads of
day 10 and 11 were individual pools prepared from 20 mouse
embryos, and therefore not marked with error bars. Data of day 13
were generated by three pools for each body part consisting of 3-5
individuals. For day 16 and 19 the body parts of three individuals
were prepared independently. Data of days 13, 16, 19 are shown as
means ± SEM. To compare fibin expression between embryonic and
adult tissues qPCR was performed together with samples prepared
from adult liver and cerebellum. (C) Fibin expression in human and
murine cell lines is given as x-fold over expression levels in T98G
cells and RAW264.7 cells, respectively. Data are shown as means ±
SEM from three independent cell preparations. Significant
differences are marked with *p < 0.05, **p < 0.01, ***p < 0.001
using the Student’s unpaired t-test.
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Page 2 of 11found in the cerebellum and skeletal muscle. High expres-
sion levels of fibin mRNA were not only present in
limbs of the mice at days 13 and 16 but also in the trunk
(Figure 2B). Overall fibin expression was higher in fetal
than adult tissues.
Next, we screened several human and mouse cell lines
for possible fibin expression. Significant mRNA levels
were found in HEK293, HT29, HepG2, and L929 cells
(Figure 2C), whereas T98G and RAW264.7 cells pre-
sented very low fibin mRNA levels. Other human
(LN405, K562, U937), mouse (P815, WEHI3B, X63) and
rat (RBL2H3) cell lines showed no detectable fibin
mRNA (not shown).
To analyze fibin expression regulation, L929 and
HEK293 cells were incubated with various compounds
known to have effects on the expression of other genes. As
shown in Figure 3A, manganese chloride significantly
increased fibin expression in L929 cells. The highest levels
were obtained after 16 hours. Dexamethasone and phorbol
ester also significantly increased fibin expression but to a
lesser extent than manganese chloride (Figure 3B). In
HEK293 cells (Figures 3C and 3D), none of the com-
pounds tested had any effect on the fibin mRNA level.
All attempts to quantify endogenous fibin expression in
embryonic and adult tissues and cell lines at the protein
level failed so far, probably because the protein amounts
were below Western blot sensitivity (data not shown).
Further, specific detection after enrichment of fibin from
tissue (mouse and pig brains, 10 g and 200 g, respectively)
and from cell line (HEK293, L929; 300-500 mill. cells)
extracts by immunoprecipitation and immunoaffinity
chromatography followed by Western blotting was unsuc-
cessful. Both antibodies, against the whole protein and
C terminus, have a detection limit of approximately
400 fmol fibin per lane (heterologously expressed in E. coli
and purified) in Western blots indicating that amounts of
fibin from tissue and cell extracts were below this concen-
tration. Posttranslational proteolytic processing, as cause
for the lack of immunodetection, can almost be excluded
because posttranslational cleavage sites of prohormone
convertases (PrpP 1.0 http://www.cbs.dtu.dk/services/
ProP/ or conserved neighboured basic amino acid motifs
were not identified.
To further address the mechanism of transcriptional
regulation of fibin, human genomic sequences (up to
2.5 kbp upstream the translation start) were cloned into
the firefly luciferase gene containing the pGL3 reporter
vector (Figure 4A and 4D). The transcriptional start is
located between -415 bp and -359 bp upstream of the
translational start and there is no intron in the 5’ UTR
(for details, see Additional file 1, Figure S1). Maximum
promoter activities in both, L929 and HEK293 cells
were found with constructs containing -836 bp
upstream of the genomic sequence (Figures 4B and 4E)
indicating similar regulation of basal transcription in
both cell lines. Mouse RAW264.7 cells and human
T98G cells served as the respective negative controls
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Figure 3 Effects of additives on fibin expression in L929 and
HEK293 cells. L929 or HEK293 cells were incubated with (A) 300
μM MnCl2 or (B) with either 10 mM lithium chloride, 25 μM
forskolin, 10 μM dexamethasone, or 10 μM phorbol ester (final
concentrations) for indicated times. Then, samples were analyzed by
real-time PCR. Data are given as means ± SEM of x-fold stimulation
over controls of three independent experiments using the Student’s
unpaired t-test. Significant differences between experimental and
control conditions are marked with *p < 0.05, **p < 0.01,
***p < 0.001.
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Figure 4 Reporter assays with different fibin promoter lengths.
(A, D) Various lengths of human genomic sequences upstream of
the fibin translation start were amplified and cloned into a pGL3
vector. Murine (B) L929 cells and (C) RAW264.7 cells as well as
human (E) HEK293 cells and (F) T98G cells were transfected with the
various promoter constructs. RAW264.7 cells and T98G cells served
as the respective mouse and human negative controls because no
endogenous fibin-mRNA expression was found (see Figure 2C).
Luciferase activity was measured 48 h later and normalized to
luciferase activity driven by an SV40 promoter with average values
of 2,483 cps (L929 cells), 21,975 cps (HEK293), 12,896,311 cps
(RAW264.7 cells), and 147,769 cps (T98G cells). Data are given as
mean ± SEM of four to seven independent experiments.
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Page 3 of 11because no endogenous fibin mRNA expression was
found in either cell lines (Figures 4C and 4F).
To analyze whether the 2.5-kbp-promoter construct
contains regulatory sites, transfected L929 and HEK293
cells were incubated with dexamethasone, phorbol ester
and manganese chloride. As shown in Figure 5, signifi-
cant regulation of luciferase activities by these three
compounds was found in L929 cells but not in HEK293
cells.
Subcellular distribution of fibin
To study the subcellular distribution of fibin a C-term-
inally GFP-tagged version was heterologously expressed
in COS-7 cells. As demonstrated in Figure 6A fibin-GFP
transfected cells displayed a reticular fluorescence
pattern suggesting association of fibin with the ER.
Co-immunostaining with an antibody against the ER-
specific protein calnexin showed co-localization (Figure 6B).
Only a very low signal overlap was seen with Golgi-
specific protein GM130 (Figure 6C). An identical subcel-
lular distribution was found for wild-type fibin using the
mouse fibin-specific antibody (Figure 6D). Because no
structural signatures of transmembrane domains were
predicted we speculate that the N terminus contains a
signal sequence guiding the protein to the ER. To address
this hypothesis we generated an N-terminally truncated
fibin-GFP construct starting with the methionine at posi-
tion 28. As shown in Figure 6E this construct was homo-
genously distributed in the cell indicating that the
deleted N terminus contained a signal sequence for ER
localization.
To finally verify whether the putative ER-targeting sig-
nal is cleaved from the precursor protein we purified a
fibin construct C-terminal tagged with His6 from COS-7
cells under denaturating conditions and sequenced the
N terminus by the Edman method (see Methods). The
native N terminus started with the amino acids Tyr-
Phe-Asp, which correspond to the amino acid positions
19 to 21 in fibin. This indicates that fibin contains an
N-terminal signal sequence of 18 amino acids which is
removed by cleaving between Gly
18 and Tyr
19.
Posttranslational modifications and molecular forms of
fibin
To further substantiate the molecular architecture of
fibin, protein isolation and Western blot studies were
performed. Ortholog alignment and analysis of the fibin
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Figure 5 Effects of additives on the activity of a transfected
fibin-promoter construct. L929 cells and HEK293 cells were
transfected with the 2.5-kbp-fibin promoter construct. After 24 h, 10
μM dexamethasone, 10 μM phorbol ester, and 300 μM MnCl2 were
added. Cells were lysed after the indicated time of incubation and
luciferase activity was measured. Results (controls: white bars;
compounds: grey bars) are shown as means of relative luciferase
activity ± SEM of four (L929 cells) and three (HEK293 cells)
experiments. Significant differences between sample and control
conditions are marked with *p < 0.05, **p < 0.01, ***p < 0.001 using
the Student’s unpaired t-test.
A B C
D E
Figure 6 Subcellular localization of fibin in COS-7 cells. Confocal
fluorescence images (LSM 510, Zeiss) show (A) fibin-GFP, (B) merge
(yellow) of fibin-GFP (green) with the ER marker calnexin (red), (C)
merge (yellow) of fibin-GFP (green) with the Golgi marker GM130
(red), (D) merge (yellow) of fibin, detected with anti-fibin-antibody-
1/anti-rabbit-IgG-FITC (green) and the Golgi marker GM130 (red),
and (E) Δ1-27-fibin-GFP.
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Page 4 of 11amino acid sequence by prediction software revealed an
N-terminal signal sequence for ER entry and a con-
served N-glycosylation site (see Additional file 2, Figure
S2). The theoretical molecular weights of murine non-
glycosylated full length fibin and fibin without the signal
sequence were calculated as 24.8 kDa and 22.6 kDa,
respectively. As demonstrated in Figure 7A, fibin
appeared at 26 kDa in both the soluble and membra-
nous fractions of transfected COS-7 cells. Furthermore,
we studied fibin glycosylation, a clear marker for ER/
Golgi passage. Deglycosylation with PNGase F and
mutation (N
30Q) of the potential N-glycosylation site at
amino acid position 30 led to the calculated size of
approximate 23 kDa (Figure 7B). Fibin heterologously
expressed in E. coli w a su s e da sac o n t r o la si tw a st h e
same size as the two deglycosylated forms (Figure 7B).
Fibin contains two conserved Cys (Cys
52, Cys
64) residues
(see Additional file 2, Figure S2). Mutagenesis studies
together with SDS-PAGE/Western blot analyses under
non-reducing and reducing conditions were performed to
test whether these Cys residues participate in intra- and/or
intermolecular disulfide bonds. Under non-reducing con-
ditions, specific bands were found most prominently at
26 and 56 kDa, which correspond to the monomeric and
homodimeric forms of fibin, respectively (Figure 7C). The
dimeric form completely disappeared under reducing con-
ditions. None of the individual Cys mutations (Cys
52Ser,
Cys
64Ser) promoted the monomeric form. Only the double
mutant Cys
52Ser/Cys
64Ser resulted in a complete loss of
dimer formation (Figure 7C). These findings support fibin
as a dimer where two molecules are linked via two disul-
fide bonds between Cys
52-Cys
52 and Cys
64-Cys
64.I nt h e
c a s eo fo n l yo n e( e . g . ,C y s
52-Cys
64) or random disulfide
bonds one would expect an increase of the monomeric
form at least in one of the Cys mutants.
To test whether fibin also exists in non-covalent multi-
meric forms, size exclusion chromatography experiments
were performed. Protein from fibin-myc-transfected
COS-7 cells was released from microsomes by French
press treatment into hypotonic buffer. The extract was
applied to a Superdex 200 column and analyzed by size
exclusion chromatography. Fractions were separated by
SDS-PAGE under non-reducing conditions and analyzed
by a Western blot. As shown in Additional file 3, Figure
S3, a reasonable amount of SDS-resistant fibin multimers
were found in high molecular weight fractions (>158
kDa). These bands probably represent soluble aggregates.
Fibin dimers and monomers were mainly eluted in frac-
tions below 100 kDa.
Fibin is not secreted from COS-7 cells
To further address the fate of fibin, serum-free medium
supernatants of transfected COS-7 cells were collected,
concentrated by trichloroacetic acid precipitation, and
subjected to Western blot analysis. First, we analyzed
the release of fibin, c-myc-tagged version of fibin, the
secretory alkaline phosphatase (SEAP, positive control)
and GFP (negative control) after 24 h incubation with
serum-free medium. Additionally, transfected cells were
treated with brefeldin A (BFA), an inhibitor of Golgi
function that blocks the classical secretory pathway [8].
As shown in Figure 8 SEAP was only found in the med-
ium but not in cell lysates. The secretion of SEAP was
completely blocked by BFA (250 ng/ml). Fibin and
fibin-myc were detected in the cell lysates and medium.
The release of fibin and fibin-myc was not blocked by
BFA. GAPDH, an endogenous cytosolic protein, and the
heterologously expressed, cytosolic GFP were also found
in the cell lysates and medium. These results suggested
that fibin found in the medium was not actively secreted
but rather passively released after cell death. To mini-
mize unspecific release by cell damage the incubation
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Figure 7 Localization and posttranslational modification of
fibin analyzed by Western blotting. (A) To analyze the subcellular
distribution of fibin cells were harvested 72 h after transfection
followed by preparation of the homogenate, the cytosolic and the
membrane fraction. 50 μg of protein were applied to each lane. (B)
For deglycosylation experiments, fibin expressed in COS-7 cells was
incubated either with or without (w/o) PNGase F or not incubated
(w/o incubation). Furthermore, the fibin mutant N
30Q lacking the N-
glycosylation site, was expressed in COS-7 cells and fibin lacking the
signal sequence were expressed in E. coli (Fibin E. coli).
Immunoblots (A) and (B) were performed with anti-fibin-1-
antibodies. (C) Wild-type (WT) fibin, and the fibin mutants C
52S, C
64S,
C
52S/C
64S were expressed in COS-7 cells. After 72 h, cells were
harvested and lysates were prepared. Equal amounts of protein
were loaded and separated by SDS-PAGE under either non-reducing
or reducing conditions. For immunoblotting the anti-fibin-2
antibody was applied. Negative controls (NC) were prepared as
described under Methods.
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Figure 8 Protein secretion studies. COS-7 cells transfected with (A,E) fibin, (B, F) myc-tagged fibin, (C, G) SEAP, and (D, H) GFP were treated
with (A, B, C, D) 250 ng/ml Brefeldin A for 24 h or with (E, F, G, H) 50 ng/ml Brefeldin A for 6 h. Serum-free medium samples were collected
and concentrated by trichloroacetic acid precipitation. Cell lysates and medium were analyzed by Western blot using the anti-fibin-2 antibody,
anti-myc-POD antibody, anti-AP-antibody, anti-GFP antibody and anti-GAPDH antibody as well as the respective POD-labeled secondary
antibodies.
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tration (50 ng/ml) was used (Figure 8E, F, G and 8H).
SEAP was found in the supernatant whereas fibin was
only found in the cell lysate.
Discussion
Fibin is a structurally and evolutionary preserved verte-
brate protein with no amino acid homology to known
proteins (see Additional file 2, Figure S2 and Additional
file 4, Table S1). Previous studies demonstrated the
functional relevance of fibin during embryonic develop-
ment of pectoral fin bud initiation in zebrafish and limb
development in mice [1]. Indeed, fibin mRNA is embry-
onically expressed not only in forelimbs, but also in
other tissues. Furthermore, we found reasonable fibin
expression in adult tissues, with the highest expression
levels in cerebellum and skeletal muscle; however, fibin
mRNA was also present in most other tissues investi-
gated (Figure 2). These data are consistent with the
abundance of fibin EST in many different tissues includ-
ing tumors and embryonic stages in mouse and humans
indicating a role for fibin during both ontogenesis and
adolescence. Recent microarray-based gene expression
studies revealed an increase in fibin expression within a
right cardiac ventricle during chronic pulmonary embo-
lism [9]. This may suggest an involvement of fibin in
myocardial pathogenic or remodelling processes.
The fibin gene displays a simple genomic structure
without introns and a transcription start in close proxi-
mity to the translational start, AUG. Transcription regu-
lation was studied in cell lines constitutively expressing
fibin. Several compounds known to activate transcription
factors which potentially bind in the promoter region of
fibin (Figure 1) were tested. Lithium chloride activates
the transcription factors LEF/TCF of the Wnt/b-catenin
pathway via blocking GSK3b [10]. Dexamethasone, a glu-
cocorticoid, binds to intracellular receptors which act as
transcription factor. Forskolin increases cAMP via adeny-
lyl cyclase and cAMP activates protein kinase A and the
transcription factor CREB. Manganese ions can mediate
effects via the NF-B/AP-1 signalling [11,12] and the
Nrf2/ARE cascade [13]. Phorbol ester activates the pro-
tein kinase C/MAP kinase pathway. In L929 cells, but not
HEK293 cells, manganese ions, phorbol ester and dexa-
methasone induced fibin-mRNA expression with highest
mRNA levels 8-16 h after stimulation (Figure 3). The
g e n o m i cs e q u e n c e~ 8 3 6b pu p s t r e a mo ft h et r a n s c r i p -
tional start is sufficient to mediate basal transcription in
HEK293 and L929 cells, but not in human and mouse
cell lines without endogenous fibin expression (T98G,
RAW264.7; Figure 4). Interestingly, and in contrast to
L929 cells, HEK293 cells lack factor(s) which are required
for transcription regulation upon stimulation with man-
ganese ions, phorbol ester and dexamethasone (Figure 5).
Previous studies showed that fibin expression in vivo
depends on the presence of wnt2b, indicating regulation
of fibin expression by the Wnt/b-catenin pathway [1].
Indeed, there is a LEF-1/TCF target sequence upstream
of the fibin coding sequence (Figure 1). Deletion of this
sequence in our 1.52-kbp-reporter construct had no spe-
cific effect on basal luciferase activity in L929 or
HEK293 cells (data not shown). No effect on luciferase
activity was found when constitutively active catenin
was co-expressed with the 1.5-kbp-fibin promoter con-
struct in HEK293 and L929 cells. Using the TCF repor-
ter gene kit (Upstate Biotechnology, Lake Placid, NY) as
control the Wnt/b-catenin pathway was active in
HEK293 but not in L929 cells (data not shown). Fibin
expression was not increased in L929 and HEK293 cells
when transfected with constitutively active b-catenin
(data not shown). Moreover, lithium chloride, known to
activate Wnt/b-catenin pathway, had no effect on fibin
expression (Figure 3). These results indicate that the
Wnt/b-catenin pathway is probably not involved in fibin
regulation at least in the investigated cell line.
According to our in silico analysis, which predicted a
signal sequence for ER entry and a glycosylation site, we
experimentally demonstrated fibin localization in the ER
(Figure 6) and cleavage of signal sequence and glycosyla-
tion at Asn
30 (Figure 7B). SDS-PAGE under non-redu-
cing conditions and immunoblotting revealed mostly
multimeric fibin formed by an intermolecular disulfide
bond between the two cysteine residues, Cys
52 and
Cys
64, (Figure 7C). It remains unclear whether homodi-
and homomultimers are the natural forms of fibin. We
approached the quarternary structure of fibin by size
exclusion chromatography. We found almost all the
fibin in non-covalent associated multimeric complexes
(see Additional file 3, Figure S3). When expressed in
E. coli, fibin was exclusively found in inclusion bodies.
Refolding with various protocols and under different
reducing conditions led to a protein with high aggrega-
tion tendency (see Additional file 5, Figure S4). Expres-
sion of a thioredoxin-fibin fusion protein in E. coli
Origami B (thioredoxin reductase/glutathione reductase
deficient; Novagen Merck) resulted in lower inclusion
body formation, but the soluble protein also formed
multimeric complexes when analyzed by size exclusion
chromatography (see Additional file 5, Figure S4). The
high tendency of fibin to form multimeric complexes
seems to be similar to other secretory proteins, such as
adiponectin [14].
Although fibin displays properties of a secretory pro-
tein (see above), no experimental evidence for substan-
tial fibin secretion, beyond fibin release through cell
death, was found in COS-7 cells (Figure 8). This finding
is in contrast to a previous study [4] which, however,
lacked controls for unspecific release. Our data suggest
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monomer or as a homodimer formed by disulfide
bridges. The insufficient secretion found in our hetero-
logous COS-7 cell overexpression system may result
from the naturally high aggregation tendency of fibin,
which prevents proper trafficking to the Golgi complex.
In a second scenario, fibin needs escort proteins for
secretion which are not expressed in COS-7 cells. Third,
fibin forms heteromers with a yet unknown protein. The
lack of the partner protein would prevent proper folding
and trafficking, and explains the aggregation and reten-
tion tendency of fibin in ER. There are a number of
examples of the latter scenario in Wnt ligand family
members [15,16], interleukin 12 (IL-12) [17,18], and
Cbln3 [19]. At present, all attempts failed to prove or to
reject one of these hypotheses. Yeast two-hybrid experi-
ments using human fibin and a human kidney library
revealed expected interaction partners, such as chaper-
ones and the exocyst complex component 3, but no
putative fibin subunits (data not shown). Until endogen-
ous fibin is purified from natural sources, clarification of
its functional molecular structure will remain unknown.
Conclusions
Fibin appears to play a role not only during embryonic
development but also in many adult functions. Fibin
expression shows complex regulation via the signalling
pathways of protein kinase C, glucocorticoids and man-
ganese ion-activated transcriptional factors. Although
fibin displays all features of a secretory protein, proper
secretion presumably requires a currently unknown
covalently linked or associated cofactor. Because fibin is
evolutionarily old and lacks structurally related paralogs,
it may have a unique functionality; conditional gene
deficiency in mouse models may provide further insights
into its function during different ontogenetic stages and
in different tissues.
Methods
Generation of constructs for fibin expression in
mammalian and bacterial cells
Mouse fibin cDNA was amplified from mouse genomic
DNA by PCR and cloned into the mammalian expres-
sion vector pcDps. For structure-function relation stu-
dies mutations were introduced by PCR-based site-
directed mutagenesis and fragment replacement strate-
gies. For detection purposes fibin constructs were tagged
C-terminal with GFP, His6-tag or c-myc-tag. For expres-
sion in E. coli fibin cDNA was cloned into the pET21c
vector (Novagen Merck, Nottingham, UK) and the
pET32b vector (Novagen), respectively (Detailed infor-
mation see Additional file 6, Table S2).
For fibin promoter studies 5’ genomic DNA fragments
ranging from 0.5 to 2.5 kbp were introduced into the
pGL3’basic’ vector (Promega) containing the cDNA for
the reporter luciferase. As positive control the SV40
promoter was cloned into the pGL3’basic’ vector. A con-
struct (Neg1520) containing 1.5 kbp (5’ of the fibin cod-
ing sequence) genomic sequence in reversed orientation
served as negative control.
All PCR-derived constructs were confirmed by restric-
tion enzyme analysis and DNA sequencing.
Real-time PCR for quantification of fibin
Total RNA was isolated from tissues, HEK293 and L929
cells using Trizol (Invitrogen, Karlsruhe, Germany). To
obtain embryonic tissues at defined post coital stages
mice were fertilized by superovulation according to a
protocol in [20]. RNA was further purified with the SV
Total RNA Isolation System (Promega, Mannheim, Ger-
many) according to the RNA clean-up protocol includ-
ing a DNAse digest. Reverse transcription of 1 μgt o t a l
RNA per reaction was carried out using oligo-dT primer
and Superscript
® II Reverse Transcriptase (Invitrogen).
cDNA from 50 ng total RNA was subjected to qPCR
using Platinum-SYBR Green
® qPCR Supermix (Invitro-
gen), 0.6 μM forward and reverse primers and 100 nM
ROX™ (5-carboxy-X-rhodamine, passive reference dye).
Oligonucleotide primers for PCR were designed with
the Primer3 software http://frodo.wi.mit.edu and are
indicated in Additional file 6, Table S2. All qPCR reac-
tions were performed with the Mx3000P instrument
(Stratagene, La Jolla, CA, USA) using the following pro-
tocol: 2 min at 50°C, 2 min at 95°C and 50 cycles of
15 s at 95°C, 30 s at 60°C. To confirm a single amplicon a
product melting curve was recorded. The correct ampli-
con size and identity was confirmed by agarose gel electro-
phoresis and sequencing or restriction enzyme cleavage.
Threshold cycle (Ct) values were set within the exponen-
tial phase of the PCR. The house keeping gene, b2-micro-
globulin was used to normalize the Ct values of the
respective fibin transcripts (ΔCt =C t -C t b2-microglobulin)
[21]. Gene expression and, accordingly, regulation was sta-
tistically evaluated by subjecting the ΔCt values to a Stu-
dent’s t-test (two-tailed, unpaired, p < 0.05). Gene
regulation was calculated as 2
-ΔΔCt and was expressed as
x-fold over reference. Phorbol ester (phorbol 12-myristate
13-acetate) and forskolin additives were dissolved in
DMSO.
Cell culture and transfection
COS-7 and HEK293 cells were grown in DMEM and L929
cells were grown in RPMI medium with both containing
glutamine, 10% fetal bovine serum (FBS), 100 μg/mL
streptomycin, and 100 units/mL penicillin at 37°C in a
humidified atmosphere of 5% CO2 and 95% air. For transi-
ent expression, cells were seeded into 6-well-plates
(for qPCR and Western blot studies), 48-well-plates
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sequencing) 24 h prior to transfection with Lipofecta-
mine 2000
® (Invitrogen) according to the manufac-
turer’si n s t r u c t i o n s .
Promoter studies
For promoter studies L929 and HEK293 cells were
transfected with the various 5’-fibin- luciferase con-
structs, washed 24 h (stimulation experiments) or 48 h
(promoter length constructs) after transfection and lysed
with 100 μl cell lysis buffer containing 77 mM K2HPO4,
23 mM KH2PO4 (pH 7.8), 0.2% Triton X-100, 1 mM
DTT. Twenty minutes after incubation on ice 20 μlc e l l
lysate was mixed with 100 μl luciferase buffer (20 mM
Tricine pH 7.8, 2.67 mM MgSO4,0 . 1m ME D T A ,
33.3 mM DTT, 270 μM acetyl-CoA, 530 μMa d e n o s i n e
triphosphate, 470 μM D-luciferin). Luciferase activity
was measured in 96-well Opti-plates (PerkinElmer,
Rodgau-Jügesheim, Germany) with multi-plate reader
Victor2 (PerkinElmer, Rodgau-Jügesheim, Germany) as
previously described [22].
Equal numbers of cells per well, identical amounts of
plasmid DNA for transfection, identical volumes of lysis
buffer and equal sample aliquots were used to ensure
for comparable measurements. The relative luciferase
activity was calculated using the following formula
(MLA = Mean of luciferase activity of triplicates or
duplicates):
Relative luciferase activity (% ) =
MLAinterest − MLAbasic
MLASV40 − MLAbasic
× 100
Generation of antibodies
To determine the cellular fate and subcellular distribu-
tion of fibin we performed studies with epitope and GFP-
tagged fibin constructs. We also generated anti-fibin anti-
bodies suitable to detect non-modified fibin. Thus, anti-
fibin antiserum was obtained by immunizing rabbits with
the peptide RLGRLKSDYLEGGAQ corresponding to
amino acid position 200 to 214 of mouse fibin. The pep-
tide was conjugated with keyhole limpet hemocyanine
(prepared by Dr. Sven Rothemund, IZKF Leipzig). To
obtain polyvalent antiserum mouse fibin was expressed
in E. coli. The isolated inclusion bodies were purified by
size exclusion chromatography followed by preparative
SDS-PAGE. After dialysis against 20 mM Hepes pH 7.5
for 24 h, fibin was incubated with 0.002 × volume 50%
glutardialdehyde (Sigma, St. Louis, USA) for 5 min at
25°C. The reaction was stopped by addition of 0.1 volume
of 1 M Tris-HCl pH 7.4, followed by dialysis against
20 mM Hepes pH 7.4 for 24 h. Efficiency of cross linking
was revised visually by SDS-PAGE. For immunization
either 200-300 μg keyhole limpet hemocyanine-coupled
peptide or approximately 700 μg cross-linked fibin were
mixed with an equal volume of complete Freund’sa d j u -
vant to immunize rabbits. After eight weeks rabbits were
boostered and blood samples were collected. The specific
antibodies were purified by affinity chromatography
using CNBr-activated sepharose 4B (GE Healthcare Bios-
ciences, Uppsala, Sweden) coupled with the peptide or
mouse fibin applying manufacturer’s protocol. Antibodies
generated by immunization with peptide conjugate and
the whole protein were referred to as anti-fibin-1-antibo-
dies and anti-fibin-2-antibodies, respectively. Both anti-
bodies were highly specific in Western blot analyses
using cell extracts from transiently transfected COS-7
cells and transformed E. coli.
Immunofluorescence studies und subcellular distribution
For immunofluorescence studies COS-7 cells were
seeded into 6-well plates containing cover slips. 72 h
after transfection cells were washed, fixed with 4% paraf-
ormaldehyde in PBS and permeabilized with 0.5% Triton
X-100 in PBS. Cells were incubated with the antibodies
indicated (Figure 5) and the following dilutions were
used: rabbit anti-fibin antisera (1:500 dilution), rabbit
anti-calnexin antibody (SIGMA, dilution 1:200) and
mouse anti-GM130 antibody (BD Biosciences, developed
in mouse, dilution 1:250). After washing, cells were
incubated with anti-mouse IgG-TRITC conjugate
(SIGMA, dilution 1:2,000) or anti-rabbit IgG-FITC con-
jugate 1:4,000 (SIGMA, St. Louis, USA) diluted. After
washing again, cells were incubated with 4’,6 - d i a m i -
dino-2-phenylindoldihydrochloride (DAPI, Merck) for
2 min and washed. Finally, cover slips were mounted with
Fluoromount (Molecular Probes, Eugene, USA). For pre-
paration of cytosolic and membrane fractions COS-7 cells
transfected for 48 h with fibin-pcDps construct were
homogenized in ice-cold buffer containing 50 mM Tris-
HCl pH 7.4, 250 mM sucrose, 1 mM EDTA and protease
inhibitor mix (Sigma) by ultra sonication. The homoge-
nates were centrifuged at 1,000 g and 4°C for 5 min to
remove cell debris. The supernatant was centrifuged at
100,000 g and 4°C for 1 h. The resulting supernatant was
collected and the pellet was resuspended with homogeni-
zation buffer. Protein concentrations of the fractions were
estimated by the Bradford method.
Edman sequencing and PNGase F treatment of fibin
COS-7 cells were transfected with fibin-His6-pcDps and
harvested 72 h after transfection. Cells were lysed
(50 mM Tris-HCl pH 7.4, 8 M urea, 150 mM NaCl),
ultra sonication treated and centrifuged at 20,000 g for
20 min at 10°C. The supernatant was incubated with
1m lo fN i
2+-IDA-Sepharose in a closed column for
30 min at room temperature under slow spinning.
Then, the column was washed (50 mM Tris-HCl pH
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protein was eluted (50 mM Tris-HCl pH 7.4, 8 M urea,
150 mM NaCl, 200 mM imidazole) and precipitated
with trichloroacetic acid. The pellet was resuspended in
sample buffer, boiled and subjected to SDS-PAGE. After
electroblotting to PVDF membrane (PALL corporation,
Ann Arbor, USA) using 100 mM CAPS buffer pH 8.0
with 20% methanol and Coomassie blue staining the
protein bands from three lanes were cut and used for
N-terminal sequencing according to the Edman proce-
dure using the Protein Sequencer 473A (Applied Biosys-
tems, Foster City, CA).
For protein deglycosylation samples were treated with
PNGase (Sigma, St. Louis, USA) according to the manu-
facturer’s protocol. After incubation time for 2 h at 37°C
reaction was stopped at 94°C for 5 min.
Western blot analysis
SDS-PAGE was performed under reducing conditions, if
not otherwise indicated, with 12.5% (w/v) polyacryla-
mide gels using the Mini-Protean 3 (Bio-Rad, Munich,
Germany). After electrophoretic separation proteins
were electroblotted onto Hybond-ECL nitrocellulose
membrane (Amersham GE Health Sciences). The mem-
branes were blocked for 30 min at room temperature.
Then, blots were incubated with primary antibodies for
2 h at room temperature or overnight at 4°C. Anti-c-
myc-POD antibody (Miltenyi Biotec, Bergisch-Gladbach,
Germany), anti-alkaline phosphatase mouse antibody A-
10 (Santa Cruz Biotechnology, USA) with a dilution of
1:200, anti-GAPDH rabbit antibody (Sigma, St. Louis,
USA) 1:2,000 diluted, and 1 μg/ml affinity purified anti-
fibin-1 or anti-fibin-2 antibodies (rabbit) were used.
After washing with PBS/Tween (0.05%) anti-rabbit-IgG
conjugated with horseradish-peroxidase (1:3,000 dilu-
t i o n ,D i a n o v a ,H a m b u r g ,G e r m a n y )o ra n t i - m o u s e - I g G
conjugated with POD (Sigma) diluted 1:5,000 were used
as secondary antibodies. After 1 h of incubation and
washing blots were developed with diaminobenzidine
tetrahydrochloride or with a chemoluminescence kit
(Thermo Scientific, Rockford, USA).
For negative controls COS-7 cells were transfected
with GFP-pcDps (Figure 7) or with the empty pcDps
vector (Figure 8).
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Additional file 1: Figure S1 Putative transcript lengths and
transcription starts.
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Additional file 3: Figure S3 Size-exclusion chromatography of
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